Vimta Labs Limited — Updates, 20-07-2026: Press Release
20-07-2026 | 03:28 pm
20-07-2026 | 03:28 pm
Vimta Labs' Q1 FY27 total income rose 13.7% YoY to ₹112.9 Cr, with PAT at ₹21.0 Cr (+11.4% YoY). Pharma services saw healthy growth. New Biologics CRADS operations commenced. Food testing is adapting to headwinds via domestic market penetration.
No comments yet. Be the first to comment!
